vicks nyquil-d cold and sinus plus severe congestion

Generic: acetaminophen, pseudoephedrine hcl, doxylamine succinate, dextromethorphan hbr

Labeler: the procter & gamble manufacturing company
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name vicks nyquil-d cold and sinus plus severe congestion
Generic Name acetaminophen, pseudoephedrine hcl, doxylamine succinate, dextromethorphan hbr
Labeler the procter & gamble manufacturing company
Dosage Form CAPSULE, LIQUID FILLED
Routes
ORAL
Active Ingredients

acetaminophen 500 mg/1, dextromethorphan hydrobromide 15 mg/1, doxylamine succinate 6.25 mg/1, pseudoephedrine hydrochloride 30 mg/1

Manufacturer
The Procter & Gamble Manufacturing Company

Identifiers & Regulatory

Product NDC 84126-364
Product ID 84126-364_3c176dd2-3e1e-11e6-e063-6394a90ab264
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M012
Listing Expiration 2026-12-31
Marketing Start 2025-09-08

Pharmacologic Class

Classes
adrenergic alpha-agonists [moa] antihistamine [epc] histamine receptor antagonists [moa] sigma-1 agonist [epc] sigma-1 receptor agonists [moa] uncompetitive n-methyl-d-aspartate receptor antagonist [epc] uncompetitive nmda receptor antagonists [moa] alpha-adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 84126364
Hyphenated Format 84126-364

Supplemental Identifiers

RxCUI
2723021
UNII
362O9ITL9D 9D2RTI9KYH V9BI9B5YI2 6V9V2RYJ8N

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vicks nyquil-d cold and sinus plus severe congestion (source: ndc)
Generic Name acetaminophen, pseudoephedrine hcl, doxylamine succinate, dextromethorphan hbr (source: ndc)
Application Number M012 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/1
  • 15 mg/1
  • 6.25 mg/1
  • 30 mg/1
source: ndc
Packaging
  • 12 CAPSULE, LIQUID FILLED in 1 BOTTLE (84126-364-12)
source: ndc

Packages (1)

Ingredients (4)

acetaminophen (500 mg/1) dextromethorphan hydrobromide (15 mg/1) doxylamine succinate (6.25 mg/1) pseudoephedrine hydrochloride (30 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3c176dd2-3e1e-11e6-e063-6394a90ab264", "openfda": {"unii": ["362O9ITL9D", "9D2RTI9KYH", "V9BI9B5YI2", "6V9V2RYJ8N"], "rxcui": ["2723021"], "spl_set_id": ["3c176ea9-62a0-b86f-e063-6294a90ab8f7"], "manufacturer_name": ["The Procter & Gamble Manufacturing Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "12 CAPSULE, LIQUID FILLED in 1 BOTTLE (84126-364-12)", "package_ndc": "84126-364-12", "marketing_start_date": "20250908"}], "brand_name": "Vicks NyQuil-D COLD and SINUS plus SEVERE CONGESTION", "product_id": "84126-364_3c176dd2-3e1e-11e6-e063-6394a90ab264", "dosage_form": "CAPSULE, LIQUID FILLED", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Antihistamine [EPC]", "Histamine Receptor Antagonists [MoA]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "84126-364", "generic_name": "Acetaminophen, Pseudoephedrine HCl, Doxylamine Succinate, Dextromethorphan HBr", "labeler_name": "The Procter & Gamble Manufacturing Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Vicks NyQuil-D", "brand_name_suffix": "COLD and SINUS plus SEVERE CONGESTION", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "500 mg/1"}, {"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "15 mg/1"}, {"name": "DOXYLAMINE SUCCINATE", "strength": "6.25 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20250908", "listing_expiration_date": "20261231"}